Strategic Analysis of Indian Biosimilar Market
10-May-2011
Asia Pacific
Market Research
P43E-01-00-00-00
HC02321-AP-MR_08313
This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the biosimilars, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developments. The research deliverable also covers the overview of the other major biosimilar players like China. The research service also gives a deeper insight into the profiles of the companies that are into this segment in India. It also covers the historical trends and future impacts on Biosimilar Markets.
Brief Summary of Indian Biosimilar Market
- Executive Summary of the Biosimilar market
- Future Impact
Overview of Global Biosimilar Market
- Introduction to Biosimilars
- Global Population Demographics
- Key Biodrugs
- Types of Products Manufactured by Major Participants
- Market Size of Biosimilars: Global
- Market Size: Biologic Patents Expiring in 2011-2016
- Market Size: Biologics Patents Expiring 2016-2019
- Market Size : Worldwide Sales of Key Biodrugs
- Market Opportunities
- Market Size of Biosimilars: Revenue Forecasts
- Major Participants - Global
- Major Participants - Trends
Overview if Indian Biosimilar Market
- Overview of Indian Biosimilar Market
- Timeline of Indian Market
- Indian Market Portfolio
- Domestic Market Potential
- Market Drivers Ranked in Order of Impact
- General Factors favoring the market
- Market Restraints Ranked in Order of Impact
- Hurdles faced by Indian Participants
- Domestic Market Potential - Observed Trends in Market
- Export Potential - Overview
- Export Potential - Expansion Strategy of Indian Participants
- Overview of Highly Regulated Markets: Europe
- Overview of Highly Regulated Markets: The United States
- Overview of Semi-regulated Markets: China
- Cost Advantage of India
- Biosimilar Market in India: Revenue Forecasts
Overview of Regulatory Scenario
- Indian Regulations for Biosimilars
- International Regulatory Authorities European Medicines Agency (EMA)
- International Regulatory Authorities US-FDA
Overview of Major Participants in the Indian Market
- Biocon
- Dr. Reddy’s
- Ranbaxy
- Wockhardt
- Intas Biopharmaceuticals
- Shantha Biotech
Overview of Historical trends and Future Impact
- 2001-2010: A Historical View of the Biosimilar Market
- 2010-2015: Frost & Sullivan View on the Biosimilars Market
Overview of Chinese Biosimilar Market
- Overview of Biosimilar Market in China
- China – Major Participants
Frost and Sullivan: Overview
- Who is Frost and Sullivan
- What makes us unique
- T.E.A.M. Methodology
- Global Perspective
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
08 Oct 2026 | Global | Frost Radar
Frost Radar: Endoscopy Device Technology Ecosystem, 2026
The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...
07 Oct 2026 | Global | Technology Research
Growth Opportunities in Image-Guided Cancer Ablation Systems
Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | P43E-01-00-00-00 |
| Is Prebook | No |
Strategic Analysis of Indian Biosimilar Market
$4,950.00
Special Price $3,712.50 save 25 %